BB BIOTECH AG - 13 Jan 2025 SCHEDULE 13G/A Report for Sage Therapeutics, Inc. Common Stock (SAGE)

Filing Manager: BB BIOTECH AG
Reporting Manager: BB Biotech AG
Security: Sage Therapeutics, Inc. Common Stock
Symbol: SAGE
Shares outstanding: 62M shares
Disclosed Ownership: 1.18M shares
Ownership: 1.9%
Form type: SCHEDULE 13G/A
Filing time: 17 Jan 2025, 06:02:29 UTC
Date of event: 13 Jan 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BB Biotech AG	1.9%	1.18M	0	1.18M	/s/ Martin Gubler	Martin Gubler
Biotech Target N.V.	1.9%	1.18M	0	1.18M	/s/ Jan Bootsma	Jan Bootsma